Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with ...

AstraZeneca announced on Saturday that it has developed a promising new treatment for hypertension, potentially benefiting approximately 650,000 individuals who suffer from this condition. The ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

The human body is often described in parts—different limbs, systems, and organs—rather than something fully interconnected and whole. Yet many bodily processes interact in ways we may not always ...

Patients with therapeutic intensification of pharmacological pressure-unloading therapy had marked improvements in cardiac load, the study found, as demonstrated by reductions in N-terminal pro-B-type ...

A new review in The Lancet highlights breakthrough therapies that could replace daily blood pressure pills with just two ...

A new Lancet review highlights innovative hypertension treatments, including twice-yearly injections that may offer long-lasting blood pressure control.

Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of Fox 17. Hypertension, or high blood pressure, affects over a billion people worldwide ...

Nearly half of all adults in the U.S. had hypertension between August 2021 and 2023, though men were less likely to be aware of their status. The CDC released the latest findings from the National ...

Investing.com -- Medtronic plc (NYSE:MDT) announced Thursday that Japan’s Ministry of Health, Labour and Welfare has granted reimbursement approval for its Symplicity Spyral renal denervation system ...